The Valley Desk

NCT00101985 · Interventional trial

Eight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome (IBS)

Overall registry status Completed

Phase 2

Conditions Irritable Colon

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov